It has long been known that medication payments to doctors influence how many spiro prescriptions they write. But a study published Friday offered the first proposal, which could also be linked to toll overruns in their communities.
The aggressive release of drugs over the last 20 years has been blamed for the vast number of victims of the opioid epidemic.
The new study, published in JAMA Network Open shows that counties receiving such payments later experience higher overdose mortality – even when researchers control many other possible influences. 19659003] The study does not prove a causal link; the relationship between the two is an association.
The study also suggests that consistent trust visits ̵
. , which seems to be the most important thing, is not the amount of money paid to doctors, that's the number of their payments, "says Magdalena Serda, associate professor of healthcare for the population and director of the Center for Opioid Epidemiology. and policy at the New York University Medical School.
Michael Barnett, Harvard University's Health Policy and Governance Assistant Chan's Public Health School, who has studied the physicians' role in the opiate epidemic, called the conclusions "deeply concerned about the raging [opioid] crisis that we all know . " The annual number of prescriptions for painkillers such as oxycodone, hydrocodone and methadone has declined in recent years as doctors, states, and public health authorities have responded to the opioid epidemic.
However, overdoses of these drugs killed nearly 18,000 people in 2017. Centers for disease control and prevention, even when illegal fentanyl has become the main driver of the opioid crisis
Prescription drugs, not heroin or fentanyl, are often the first opioid users are exposed to, opioid prescription drug marketers
but researchers said their study was the first to expand the comparison with overdose deaths.
The new study coincides with federal overdose death data in each county from August 1, 2014 to December 31, 2016, with doctors' fees for food, speech, consultations and travel for the period from August 1, 2013. until December 31, 2015.
The lag is an attempt to ensure that payments affect prescription rather than high-prescription physicians who attract larger payments from pharmaceutical companies
In March, researchers from Harvard and CNN published an analysis , which showed that doctors who prescribe more opioids, have attracted more drug payments. companies.
Barnett said that regardless of how the payments work, they are influential. Known in trade as "detailed," these efforts influence decision-makers' decision-making, he said. "What it does is create awareness … It will be closer to the top of your mind." The new study found that 434,754 payments totaling $ 39.7 million for 67,507 doctors – about 1 each 12 doctors.The researchers found that 1 out of 5 family doctors received this type of marketing
"Populations receiving such marketing have been experiencing increased mortality," they write. opiates are heavily linked to the burden of opiates
In most of the country, this type of marketing is legal and neo indeterminate.
Another author of the study, Scott Hadland, a pediatrician and researcher at Boyden's Medical Center at the Grayken Addiction Center, said drug dealers. plays a legitimate role in training doctors for medicines
But he said doctors have other ways to learn about drugs like conferences and continuing education. To reduce overdose deaths, doctors, pharmaceutical companies and the government may need to regulate trade, he said. In 1967, a regulation was created in New Jersey, which limits the amount of cash they can get from pharmaceutical companies. Last year Purdue Pharma, the manufacturer of OxyContin, stopped selling opiates to doctors.
Pharmaceutical research and manufacturers in America, the major drug industry group, said in a statement that prescribers are involved in managing patients with pain, "they need to be informed about the basics of acute and chronic pain management, the range of options available treatment and relevant benefits and risks. "
2018 © The Washington Post
] This article was published by The Washington Post .